Drug Shortage Report for PDP-ERYTHROMYCIN
Report ID | 227343 |
Drug Identification Number | 01912755 |
Brand name | PDP-ERYTHROMYCIN |
Common or Proper name | Erythromycin |
Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | ERYTHROMYCIN |
Strength(s) | 5MG |
Dosage form(s) | OINTMENT |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 50 x 1g |
ATC code | S01AA |
ATC description | ANTIINFECTIVES |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | |
Actual start date | 2024-05-03 |
Estimated end date | 2024-09-30 |
Actual end date | 2024-10-25 |
Shortage status | Resolved |
Updated date | 2024-10-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-10-28 | French | Compare |
v5 | 2024-10-28 | English | Compare |
v4 | 2024-07-30 | French | Compare |
v3 | 2024-07-30 | English | Compare |
v2 | 2024-05-08 | French | Compare |
v1 | 2024-05-08 | English | Compare |
Showing 1 to 6 of 6